Abstract

Purpose : To determine the perturbation effect in the surface layers of lesions located in the air-tumor tissue interface of larynx using 60Co, 6 MV, and 10 MV photon beams. Methods and Materials : Thermoluminescent dosimeters (TLDs), were embedded at 16 measurement locations in slab no. 8 of a humanoid phantom and exposed to two lateral-opposed beams using standard small 7 × 7 cm fields. Similarly, radiographic and radiochromic films were placed between slabs no. 7 and no. 8 of the humanoid phantom and exposed to two lateral-opposed radiation beams. The dosimeters were irradiated with 60Co, 6 MV, and 10 MV photon beams. Computer tomography (CT) treatment planning without inhomogeneity correction was performed. Results : At the tissue-air interface, the average measured percentage dose (% dose m) is about (108.7 ± 4.8)% with TLD data, (96.8 ± 2.5)% with radiographic film data, and (100.8 ± 4.9)% with radiochromic film data. Similarly, in the central part of the cavity, the % dose m is (98.4 ± 3.1)% with TLD data, (94.3 ± 3.3)% with radiographic film data, and (91.7 ± 5.0)% with radiochromic film data. Using the CT-based generated dose distribution (without inhomogeneity correction), the average calculated percentage dose (% dose c is (98.7 ± 1.0)% at the tissue-air interface and 98% in the central part of the air cavity. Conclusion : For the beam energies studied, the variation from the % dose m at the tissue-air interface for a given dosimetry technique is relatively small [< 5% (TLD), < 3% (radiographic), and < 5% (radiochromic)] and therefore should not be significant in clinical settings. The variation from the % dose m at the tissue-air interface is more significant for lower energies [8% ( 60Co), 7.3% (6 MV)]. This variation is about 4.3% for 10 MV photon beam, therefore, while our institutional practice favors lower energy ( 60Co to 6 MV) for node-negative glottic cancers, physical/dosimeterc evidence offers no disadvantage to the use of higher energy photons.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.